Company Overview
More
Dong Rui Pharmaceutical (Holdings) Co., Ltd. is an investment holding company, mainly engaged in the development, manufacture and sales of generic drugs. Products include intermediates, APIs and proprietary medicines. The company operates through two business units. The Intermediates and API Department is engaged in the manufacture and sale of intermediates and APIs. The proprietary Medicine Department is engaged in the manufacture and sale of proprietary medicines, including antibiotic preparations and non-antibiotic preparations.
CEO： Qiling Li
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
02348 DAWNRAYS PHARMA
1.1200.0000.00%
Trading Session 05/24 09:00 CCT
High
0.000
Open
0.000
Turnover
0
Low
0.000
Pre Close
1.120
Volume
0
Price Forecast
No Data
News
Comment
DAWNRAYS PHARMA: 2021 Annual Report
DAWNRAYS PHARMA: ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
DAWNRAYS PHARMA: DATE OF BOARD MEETING
DAWNRAYS PHARMA: 2021 INTERIM REPORT
DAWNRAYS PHARMA: Announcement of Interim Results for the six months ended 30 June 2021
DAWNRAYS PHARMA: DATE OF BOARD MEETING
DAWNRAYS PHARMA: 2020 Annual Report
DAWNRAYS PHARMA: ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
DAWNRAYS PHARMA: DATE OF BOARD MEETING
DAWNRAYS PHARMA: 2020 INTERIM REPORT